Calvepen 333 mg Tablets
Authorisation PA0126/137/001 · Clonmel Healthcare Ltd
- Licence holder
- Clonmel Healthcare Ltd (all products →)
- Active substance
- PHENOXYMETHYLPENICILLIN CALCIUM
- Clinical trials
- 2 clinical trials →
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC codes
- J01CE, J01CE02
- First authorised
- 01/04/1977
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
PHENOXYMETHYLPENICILLIN CALCIUM: supply and approvals
8 authorised products on the HPRA list contain PHENOXYMETHYLPENICILLIN CALCIUM. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- 1 supply notice, e.g. Pen 0,4 Mega TS - 1 A Pharma (30 Sep 2026 to 30 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 49 years (since 1 April 1977). The HPRA list marks it as marketed in Ireland.
Other medicines with PHENOXYMETHYLPENICILLIN CALCIUM in Ireland
2 other products on the HPRA list contain PHENOXYMETHYLPENICILLIN CALCIUM, from 1 licence holder; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Calvepen 250 mg/5 ml Powder for Oral Suspension | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Calvepen 666 mg Tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
Other substances in ATC group J01CE
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 3 other active substances share the group J01CE with this product:
Phenoxymethylpenicillin potassium (3) · Phenoxymethylpenicillin (2) · Benzylpenicillin Sodium (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Clonmel Healthcare Ltd holds 429 products on the HPRA list, with 174 different active substances; 325 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.